This study sought to determine whether outcomes for transfemoral ( TF ) transcatheter aortic valve replacement ( TAVR ) differ between the randomized controlled trial ( RCT ) and the subsequent NRCA ( Nonrandomized Continued Access ) registry of the PARTNER ( Placement of AoRTic TraNscathetER Valves ) trial .